Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes
Abstract Protocols for clinical trials describe inclusion and exclusion criteria based on general and compound‐specific considerations to ensure subject safety and data quality. In phase I clinical trials, healthy volunteers (HVs) are screened against these criteria that often specify predefined eli...
Saved in:
Main Authors: | Annemie Deiteren (Author), Erwin Coenen (Author), Sabine Lenders (Author), Peter Verwilst (Author), Erik Mannaert (Author), Freya Rasschaert (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers
by: Annemie Deiteren, et al.
Published: (2024) -
Incidental findings in UK healthy volunteers screened for a COVID‐19 vaccine trial
by: Susanne H. Hodgson, et al.
Published: (2022) -
Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development
by: Mariam A. Ahmed, et al.
Published: (2020) -
Screening for endocrine hypertension. An Endocrine Society scientific statement
by: William F. Young Jr, et al.
Published: (2017) -
Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
by: Mohammad Al‐Mahdi Al‐Karagholi, et al.
Published: (2021)